Emricasan (IDN-6556) - Moligand™, 10mM in DMSO , Caspase inhibitor, CAS No.254750-02-2, Caspase inhibitor

CAS: 254750-02-2 Cat. No.: E409139 Summenformel: C₂₆H₂₇F₄N₃O₇ Molekulargewicht: 569.51

GRADE & PURITY Moligand™, 10mM in DMSO

Synonyms

PF 03491390, PF-03491390 | L-​Alaninamide, N-​[2-​(1,​1-​dimethylethyl)​phenyl]​-​2-​oxoglycyl-​N-​[(1S)​-​1-​(carboxymethyl)​-​2-​oxo-​3-​(2,​3,​5,​6-​tetrafluorophenoxy)​propyl]​-

Storage

Store at -80°C

Shipped In

Dry ice packs + Cold packs

Übersicht

Information

Emricasan (IDN-6556) Emricasan (IDN-6556, PF 03491390, PF-03491390) is a potent irreversible pan-caspase inhibitor. Emricasan is an inhibitor of Zika virus infection.
In vitro

Emricasan, also called IDN-6556 or PF-03491390, is an inhibitor of activated caspases, and it has sub- to nanomolar activity in vitro. Emricasan shows neuroprotective activity for hNPCs but does not suppress ZIKV replication.

In vivo

Emricasan decreases liver injury but not metabolic derangement in NASH. It also ameliorates inflammation. In the murine NASH model, stellate cell activation and hepatic fibrogenesis are attenuated by administration of the pan-caspase inhibitor Emricasan. Emricasan is currently being evaluated in phase 2 clinical trials for the reduction of hepatic injury and liver fibrosis caused by chronic HCV infection.
Cell Data

cell lines：

Concentrations：9 μM

Incubation Time：1 h

Powder Purity:≥98%

Specifications

Synonyme

PF 03491390, PF-03491390 | L-​Alaninamide, N-​[2-​(1,​1-​dimethylethyl)​phenyl]​-​2-​oxoglycyl-​N-​[(1S)​-​1-​(carboxymethyl)​-​2-​oxo-​3-​(2,​3,​5,​6-​tetrafluorophenoxy)​propyl]​-

Spezifikationen & Reinheit

Moligand™, 10mM in DMSO

Biochemische und physiologische Mechanismen

Emricasan (IDN-6556, PF 03491390, PF-03491390) is a potent irreversible pan-caspase inhibitor. Emricasan is an inhibitor of Zika virus infection.

Storage

Store at -80°C

Verschickt in

Dry ice packs + Cold packs

Dieses Produkt erfordert Kühlkettenversand. Grundversand und andere Economy-Optionen sind nicht verfügbar.

Note

Moligand™

Aktionsart

INHIBITOR

Mechanismus der Wirkung

Caspase inhibitor

Produkteigenschaften

• ALogP: 3.6

Namen und Kennungen

• Isomere SMILES: C[C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)COC1=C(C(=CC(=C1F)F)F)F)NC(=O)C(=O)NC2=CC=CC=C2C(C)(C)C
• Molekulargewicht: 569.51
• Reaxy-Rn: 10047524
• Reaxys-RN_link_address: https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=10047524&ln=

Zugehörige Ziele (menschlich)

CASP8 Tchem Caspase-8 (1 Activities)

Discover Target: CASP8

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

CASP3 Tchem Caspase-3 (1 Activities)

Discover Target: CASP3

Activity Type	Activity Value -log(M)	Mechanism of Action	Activity Reference	Publications (PubMed IDs)

Chemische und physikalische Eigenschaften

• Löslichkeit: Solubility (25°C) In vitro DMSO: 100 mg/mL (164.03 mM); Water: Insoluble; Ethanol: Insoluble